ESR1 and breast carcinoma: While ER-targeted therapies are widely used for breast cancer treatment and prevention, the clinical efficacy of PR-targeted therapies either alone or in combination with ER-targeted therapies is not well understood nor has it been adopted as a therapeutic choice.